套住了 止损查看全文
牛唐2020-06-19 14:01
生物医药领域成为疫情期间IPO的亮点,在过去两个月里,包括$Lyra Therapeutics(LYRA)$ 在内,有4家上市公司都属于生物医药的范畴,包括$ORIC制药(ORIC)$ ,$Keros(KROS)$ ,以及Zentalis Pharmaceuticals。这些生物医药公司不仅顺利IPO,而且平均回报率达82%查看全文
$Lyra Therapeutics(LYRA)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-22-041882 Act: 34 Size: 83 KB 网页链接
$Lyra Therapeutics(LYRA)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001172661-22-000690 Act: 34 Size: 54 KB 网页链接
$Lyra Therapeutics(LYRA)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001564590-21-055778 Act: 34 Size: 7 MB 网页链接
$Lyra Therapeutics(LYRA)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001564590-21-055751 Act: 34 Size: 458 KB 网页链接
$Lyra Therapeutics(LYRA)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000899243-21-036126 Size: 7 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-21-036132 Size: 5 KB 网页链接
$Lyra Therapeutics(LYRA)$ 8-K Current report, item 5.02 Accession Number: 0001564590-21-048046 Act: 34 Size: 172 KB 网页链接
$Lyra Therapeutics(LYRA)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001564590-21-042711 Act: 34 Size: 8 MB 网页链接
$Lyra Therapeutics(LYRA)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001564590-21-042668 Act: 34 Size: 471 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-21-025288 Size: 4 KB 网页链接